Robert Paul Harris, Director at Aralez Pharmaceuticals Inc. (ARLZ), sold 229,556 shares at $4.65 ($1.1M) on 2016-11-28, disclosed to the SEC on 2016-11-30.
Open-market sale of $1.1M ARLZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.65 | 20,000 | $93K | 8.2% |
| 2 | $4.99 | 104,778 | $523K | 45.9% |
| 3 | $4.99 | 104,778 | $523K | 45.9% |
| Total | $4.96 avg | 229,556 | $1.1M | 100% |
| Filing → |